NVIDIA Wins China Sales Approval: Will H20 Chip Deal Boost Growth?

NVIDIA has secured U.S. government approval to sell its H20 AI chips in China, a crucial development enabling the company to re-enter a significant market previously impacted by export restrictions. While the agreement stipulates a 15% revenue share from H20 sales in China, this access is expected to help NVIDIA recover lost market share, bolster its overall revenue base, and maintain its leadership in AI chip technology, despite the potential slight margin impact. This move is projected to significantly contribute to NVIDIA's revenue growth, with fiscal 2026 revenues estimated to grow 52.2% year-over-year.

Analysis

NVIDIA Corporation has secured a pivotal agreement with the U.S. government, permitting the sale of its H20 AI chips into the Chinese market. This development significantly alters the company's near-term outlook, as it directly addresses the substantial revenue losses incurred from prior export restrictions, which were estimated to reach $8 billion in lost sales for Q2 fiscal 2026 alone. The primary condition of the deal is a 15% revenue-sharing payment to the U.S. government on all H20 sales in China, which introduces a direct headwind to gross margins on these specific sales. However, regaining access to China's vast AI market is expected to more than compensate for this, potentially reversing the decline in the region's revenue contribution, which had fallen from over 21% in fiscal 2023 to 13% in fiscal 2025. This strategic move is supported by strong forward-looking analyst estimates, including a Zacks Consensus Estimate for 52.2% year-over-year revenue growth in fiscal 2026 and upward revisions to earnings forecasts. Despite this positive catalyst, NVIDIA operates in an increasingly competitive environment with AMD and Intel advancing their own AI chip solutions, and the stock trades at a premium forward price-to-earnings ratio of 36.66, well above the sector average of 28.

Key Decisions for Investors

• The approval to re-enter the Chinese market significantly de-risks NVIDIA's revenue forecast and provides a clear catalyst for growth, which may justify its premium valuation for investors with a long-term bullish outlook on AI.
• It is crucial to monitor the net impact of the 15% revenue-sharing agreement on NVIDIA's gross margins in subsequent financial reports to determine if the increased sales volume in China effectively offsets the direct cost.
• Given the stock's 36.4% year-to-date gain and high P/E ratio, investors should weigh this positive development against the intensifying competitive landscape, where rivals like AMD and Intel are positioning their products as cost-effective alternatives.